9 authorised products containing Alogliptin (as benzoate), from the HPRA register.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Incresync 12.5 mg/30 mg film-coated tablets EU/1/13/842/01-09 |
Alogliptin (as benzoate), Pioglitazone (as hydrochloride) | Takeda Pharma A/S | — |
| Incresync 12.5 mg/45 mg film-coated tablets EU/1/13/842/010-018 |
Alogliptin (as benzoate), Pioglitazone (as hydrochloride) | Takeda Pharma A/S | — |
| Incresync 25 mg/30 mg film-coated tablets EU/1/13/842/019-027 |
Pioglitazone (as hydrochloride), Alogliptin (as benzoate) | Takeda Pharma A/S | — |
| Incresync 25 mg/45 mg film-coated tablets EU/1/13/842/028-036 |
Pioglitazone (as hydrochloride), Alogliptin (as benzoate) | Takeda Pharma A/S | — |
| Vipdomet 12.5 mg/1000 mg film-coated tablets EU/1/13/843/013-024 |
Alogliptin (as benzoate), Metformin Hydrochloride | Takeda Pharma A/S | — |
| Vipdomet 12.5 mg/850 mg film-coated tablets EU/1/13/843/001-012 |
Metformin Hydrochloride, Alogliptin (as benzoate) | Takeda Pharma A/S | — |
| Vipidia 12.5 mg film-coated tablets EU/1/13/844/010-018 |
Alogliptin (as benzoate) | Takeda Pharma A/S | — |
| Vipidia 25 mg film-coated tablets EU/1/13/844/019-027 |
Alogliptin (as benzoate) | Takeda Pharma A/S | — |
| Vipidia 6.25 mg film-coated tablets EU/1/13/844/001-009 |
Alogliptin (as benzoate) | Takeda Pharma A/S | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 16 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.